FDA Commissioner Suggests Using Blockchain for New Supply Chain Open Pilot

The FDA’s supply chain tool is set to begin mainstream operations in 2023, and received Congressional approval in 2013.

The Commissioner of the United States Food and Drug Administration (FDA) has suggested the use of blockchain for an open pilot scheme for the pharmaceuticals industry. The pilot focuses on improving supply chains and was announced in a notice published Feb. 8.

The Pilot Project Program Under the Drug Supply Chain Security Act (DSCSA Pilot Project Program), which aims to ingratiate industry players with emerging innovative technologies, will accept applications through March 11.

The move is an initial step in the development of a digital supply chain platform specifically geared to tracking drugs and preventing counterfeiting, set to operate from 2023. While not confirmed, analogues of such supply chain platforms leverage blockchain technology to improve conventional systems.


Read Full Story : News

2019-02-11 11:32:00

What do you think?

0 points
Upvote Downvote

Written by Cointelegraph

Member Of Parliament Discusses EU’s Stance On Blockchain

New Platform Enables Trades Across 200 Tools and Runs Educational Crypto Show